Table 1 Phase 1 clinical trial outcomes at 6 months CGA10

From: The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity

 Placebo1.5 mg/kg5 mg/kg
# infants with respiratory re-hospitalizations at 6 months CGA3/60/60/5
# infants using bronchodilators at 6 months CGA5/60/60/5
# deaths0/71/81/7
  1. Denominators are numbers of infants with the available data
  2. CGA corrected gestational age